Suppliers / Unicorn Pharmaceuticals Pty

Unicorn Pharmaceuticals Pty

South Africa 16 employees Updated 9 July 2026

Unicorn Pharmaceuticals Pty is a finished-dose manufacturer based in South Africa. It appears in 209 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with SAHPRA (ZA), MHRA (UK) and EMA. Its GMP standing is certified by MHRA (UK) and SAHPRA (ZA).

0
active US DMFs
0
valid CEPs
2
registered plants
209
filings across 3 regulators

Registered plants

Site FDA FEI
STANMORE, United Kingdom Not on file
Cape Town, South Africa Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
SAHPRA (ZA) 184 3
MHRA (UK) 17 3
EMA 8 None

Questions about Unicorn Pharmaceuticals Pty

Does Unicorn Pharmaceuticals Pty hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Unicorn Pharmaceuticals Pty. It does have 209 filings with 3 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Unicorn Pharmaceuticals Pty manufacture?
2 registered sites are on record, in United Kingdom and South Africa (Stanmore and Cape Town). Every site is listed on this page with the register it came from.
Which regulators recognise Unicorn Pharmaceuticals Pty's GMP?
Current GMP certificates are on record from MHRA (UK) and SAHPRA (ZA). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Unicorn Pharmaceuticals Pty comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates